Ремедиум. 2019; : 27-31
Хронические заболевания вен - острая проблема современности
https://doi.org/10.21518/1561-5936-2019-11-27-31Аннотация
Список литературы
1. Бойцов С.А., Самородская И.В. Смертность и потерянные годы жизни в результате преждевременной смертности от болезней системы кровообращения. Кардиоваскулярная терапия и профилактика. 2014;13 (2):4-11. doi: 10.15829/1728-8800-20142-4-11.
2. Богачев В.Ю., Голованова О.В., Кузнецов А.Н., Ершов П.В. Хронические заболевания вен нижних конечностей: современный взгляд на патогенез, лечение и профилактику. Режим доступа: https://medi.ru/info/4739/.
3. Кудыкин М.Н. Возможности терапии симптомов хронических заболеваний вен нижних конечностей. Стационарозамещающие технологии: Амбулаторная хирургия. 2019;(1-2):34-37. doi: 10.21518/1995-1477-2019-1-2-34-37.
4. Веселов Б.А. Клинико-экономическая эффективность мини-инвазивных методов лечения варикозной болезни нижних конечностей: дис.. канд. мед. наук (In Russ.) Available at: https://www.dissercat.com/content/kliniko-ekonomicheskaya-effektivnost-miniinvazivnykh-metodov-lecheniya-varikoznoi-bolezni-ni.
5. Богачев В.Ю. Хронические заболевания вен как проблема пациентов молодого возраста. Медицинский Совет. 2015;(4):62-66. doi: 10.21518/2079-701X-2015-4-62-66.
6. Jeanneret C., Jager K.A., Zaugg C.E., Hoffmann U. Venous reflux and venous distensibility in varicose and healthy veins. Eur J Vase Endovasc Surg. 2007;34 (2):232-242. doi: 10.1016/j.ejvs.2007.03.018.
7. Воронков А.В., Гамзелева О.Ю. Обзор современных флеботропных препаратов на основе флавоноидов как перспективных эндотелиопротекторов при лечении хронических заболеваний вен. Стационарозамещающие технологии: Амбулаторная хирургия. 2019;(1-2):27-33. doi: 10.21518/1995-1477-2019-1-2-27-33.
8. Garner R.C., Garner J.V., Gregory S., Whattam M., Calam A. Comparison of the absorption of micronized (daflon 500mg) and non micronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting. Journal of Pharmaceutical Sciences. 2002;91 (1):32-40. doi: 10.1002/jps.1168.
9. Порембская О.Я., Косенко И.М. Фармакотерапия при хронических заболеваниях вен - как рационально выбрать флеботропный препарат? Флебология. 2018;(3):123-132. doi: 10.17116/flebo2018123123.
10. Silambarasan T., Raja B. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Eur J Pharmacol. 2012;679 (1-3):81-89. doi: 10.1016/j.ejphar.2011.12.040.
11. Allaert F.A. Metaanalysis of the impact of the principal venoac-tive drugs agents on malleolar venous edema. Int Angiol. 2012;31 (4):310-315. Available at: https://www.minervamedica.it/en/jour-nals/international-angiology/article.php?cod=R34Y2012N04A0310.
12. Богачев В.Ю. Обзор Материалов Международного Флебологического Конгресса (Сан-Диего, США, 27-31 августа, 2003 год). Ангиология и Сосудистая хирургия. 2004;10 (2):54-59. Режим доступа: http://www.angiolsurgery.org/maga-zine/2004/2/8.htm.
13. Савельева М.И., Сычев Д.А. Возможности трансдермальных систем доставки лекарственных средств, применяемых при хронических заболеваниях вен. Флебология. 2018;12 (1):40-49. doi: 10.17116/flebo201812140-49.
14. Богачев В.Ю., Болдин Б.В., Туркин П.Ю. Современная терапия хронических заболеваний вен нижних конечностей: в фокусе - трансдермальные флеботропные препараты. РМЖ. 2018;6 (II):61-65. Режим доступа: https://www.rmj.ru/articles/
15. Boitsov S.A., Samorodskaya I.V. Mortality and lost years of life as a result of cardiovascular premature deaths. Cardiovascular Therapy and Prevention. 2014;13(2):4-11. (In Russ.) doi: 10.15829/1728-88002014-2-4-11.
16. Bogachev V.Yu., Golovanova O.V., Kuznetsov A.N., Ershov P.V. Chronic venous diseases of the lower limbs: a modern view of pathogenesis, treatment and prevention. (In Russ.) Available at: https://medi.ru/info/4739/
17. Kudykin M.N. Possibilities of treatment of symptoms of chronic diseases of lower limbs veins. Hospital-replacing technologies: Ambulatory surgery. 2019;(1-2):34-37. (In Russ.) doi: 10.21518/19951477-2019-1-2-34-37.
18. Veselov B.A. Clinical and economic efficiency of minimally invasive techniques in the treatment of varicose veins of lower extremities. Cand. of Sci. diss. (In Russ.) Available at: https:/ www.dissercat.com/content/kliniko-ekonomicheskaya-effektivnost-miniinvazivnykh-metodov-lecheniya-varikoznoi-bolezni-ni.
19. Bogachev V.Y. Chronic venous disease as a problem in young patients. Meditsinskiy sovet = Medical Council. 2015;(4):62-66. (In Russ.) doi: 10.21518/2079-701X-2015-4-62-66.
20. Jeanneret C, Jager K.A., Zaugg C.E., Hoffmann U. Venous reflux and venous distensibility in varicose and healthy veins. Eur J Vasc Endovasc Surg. 2007;34(2):232-242. doi: 10.1016/j.ejvs.2007.03.018.
21. Voronkov A.V., Gamzeleva O.Y. Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins. Hospital-replacing technologies:Ambulatory surgery. 2019;(1-2):27-33. (In Russ.) doi: 10.21518/1995-1477-2019-1-2-27-33.
22. Garner R.C., Garner J.V., Gregory S., Whattam M., Calam A. Comparison of the absorption of micronized (daflon 500mg) and non micronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and angiologiya/Sovremennaya_terapiya_hronicheskih_zabolevaniy_ ven_nighnih_konechnostey_v_fokuse_transdermalynye_flebotropnye_preparaty/#.
23. Богачев В.Ю., Болдин Б.В., Туркин П.Ю., Лобанов В.Н. Местные препараты в лечении и снижении частоты развития нежелательных реакций после склеротерапии ретикулярных вен и телеангиэктазов. Ангиология и сосудистая хирургия. 2019;25 (4):102-107. Режим доступа: http/www.angiolsurgery. org/en/magazine/2019/4/10.htm. liquid scintillation counting. Journal of Pharmaceutical Sciences. 2002;91(1):32-40. doi: 10.1002/jps.1168.
24. Porembskaya O.Ya., Kosenko I.M. Pharmacotherapy of Chronic Venous Disease - How to Choose Appropriate Venoactive Drug? Flebologiya. 2018;(3):123-132. (In Russ.) doi: 10.17116/flebo2018123123.
25. Silambarasan T., Raja B. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Eur J Pharmacol. 2012;679(1-3):81-89. doi: 10.1016/j.ejphar.2011.12.040.
26. Allaert F.A. Metaanalysis of the impact of the principal venoactive drugs agents on malleolar venous edema. Int Angiol. 2012;31(4):310-315. Available at: https://www.miner-vamedica.it/en/journals/international-angiology/article. php?cod=R34Y2012N04A0310.
27. Bogachev V.Yu. The review of materials of the international phlebologic congress (San Diego, USA August 27-31, 2003). Angiology and Vascular Surgery. 2004;10(2):54-59. (In Russ.) Available at: http://www.angiolsurgery.org/magazine/2004/2/8. htm.
28. Savel'eva MI, Sychev DA. Potential of the Transdermal Drug Delivery Systems for the Topical Treatment of Chronic Venous Diseases. Flebologiy". Journal of Venous Disorders. 2018;12(1):40-49. (In Russ.) doi: 10.17116/flebo201812140-49.
29. Bogachev V.Yu., Boldin B.V., Turkin P.Yu. Modern therapy of chronic venous diseases of the lower limbs: focus on transdermal phlebotropic drugs. RMJ = Russian Medical Journal. 2018;6(II):61-65. (In Russ.) Available at: https://www.rmj.ru/articles/angiologiya/ Sovremennaya_terapiya_hronicheskih_zabolevaniy_ven_nighnih_ konechnostey_v_fokuse_transdermalynye_flebotropnye_prepa-raty/#.
30. Bogachev V.Yu., Boldin B.V., Turkin P.Yu., Lobanov V.N. Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia. Angiology and Vascular Surgery. 2019;25(4):102-107. (In Russ.) Available at: http://www.angi-olsurgery.org/en/magazine/2019/4/10.htm.
Remedium. 2019; : 27-31
Chronic vein diseases: a pressing issue of our time
https://doi.org/10.21518/1561-5936-2019-11-27-31Abstract
References
1. Boitsov S.A., Samorodskaya I.V. Smertnost' i poteryannye gody zhizni v rezul'tate prezhdevremennoi smertnosti ot boleznei sistemy krovoobrashcheniya. Kardiovaskulyarnaya terapiya i profilaktika. 2014;13 (2):4-11. doi: 10.15829/1728-8800-20142-4-11.
2. Bogachev V.Yu., Golovanova O.V., Kuznetsov A.N., Ershov P.V. Khronicheskie zabolevaniya ven nizhnikh konechnostei: sovremennyi vzglyad na patogenez, lechenie i profilaktiku. Rezhim dostupa: https://medi.ru/info/4739/.
3. Kudykin M.N. Vozmozhnosti terapii simptomov khronicheskikh zabolevanii ven nizhnikh konechnostei. Statsionarozameshchayushchie tekhnologii: Ambulatornaya khirurgiya. 2019;(1-2):34-37. doi: 10.21518/1995-1477-2019-1-2-34-37.
4. Veselov B.A. Kliniko-ekonomicheskaya effektivnost' mini-invazivnykh metodov lecheniya varikoznoi bolezni nizhnikh konechnostei: dis.. kand. med. nauk (In Russ.) Available at: https://www.dissercat.com/content/kliniko-ekonomicheskaya-effektivnost-miniinvazivnykh-metodov-lecheniya-varikoznoi-bolezni-ni.
5. Bogachev V.Yu. Khronicheskie zabolevaniya ven kak problema patsientov molodogo vozrasta. Meditsinskii Sovet. 2015;(4):62-66. doi: 10.21518/2079-701X-2015-4-62-66.
6. Jeanneret C., Jager K.A., Zaugg C.E., Hoffmann U. Venous reflux and venous distensibility in varicose and healthy veins. Eur J Vase Endovasc Surg. 2007;34 (2):232-242. doi: 10.1016/j.ejvs.2007.03.018.
7. Voronkov A.V., Gamzeleva O.Yu. Obzor sovremennykh flebotropnykh preparatov na osnove flavonoidov kak perspektivnykh endotelioprotektorov pri lechenii khronicheskikh zabolevanii ven. Statsionarozameshchayushchie tekhnologii: Ambulatornaya khirurgiya. 2019;(1-2):27-33. doi: 10.21518/1995-1477-2019-1-2-27-33.
8. Garner R.C., Garner J.V., Gregory S., Whattam M., Calam A. Comparison of the absorption of micronized (daflon 500mg) and non micronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting. Journal of Pharmaceutical Sciences. 2002;91 (1):32-40. doi: 10.1002/jps.1168.
9. Porembskaya O.Ya., Kosenko I.M. Farmakoterapiya pri khronicheskikh zabolevaniyakh ven - kak ratsional'no vybrat' flebotropnyi preparat? Flebologiya. 2018;(3):123-132. doi: 10.17116/flebo2018123123.
10. Silambarasan T., Raja B. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Eur J Pharmacol. 2012;679 (1-3):81-89. doi: 10.1016/j.ejphar.2011.12.040.
11. Allaert F.A. Metaanalysis of the impact of the principal venoac-tive drugs agents on malleolar venous edema. Int Angiol. 2012;31 (4):310-315. Available at: https://www.minervamedica.it/en/jour-nals/international-angiology/article.php?cod=R34Y2012N04A0310.
12. Bogachev V.Yu. Obzor Materialov Mezhdunarodnogo Flebologicheskogo Kongressa (San-Diego, SShA, 27-31 avgusta, 2003 god). Angiologiya i Sosudistaya khirurgiya. 2004;10 (2):54-59. Rezhim dostupa: http://www.angiolsurgery.org/maga-zine/2004/2/8.htm.
13. Savel'eva M.I., Sychev D.A. Vozmozhnosti transdermal'nykh sistem dostavki lekarstvennykh sredstv, primenyaemykh pri khronicheskikh zabolevaniyakh ven. Flebologiya. 2018;12 (1):40-49. doi: 10.17116/flebo201812140-49.
14. Bogachev V.Yu., Boldin B.V., Turkin P.Yu. Sovremennaya terapiya khronicheskikh zabolevanii ven nizhnikh konechnostei: v fokuse - transdermal'nye flebotropnye preparaty. RMZh. 2018;6 (II):61-65. Rezhim dostupa: https://www.rmj.ru/articles/
15. Boitsov S.A., Samorodskaya I.V. Mortality and lost years of life as a result of cardiovascular premature deaths. Cardiovascular Therapy and Prevention. 2014;13(2):4-11. (In Russ.) doi: 10.15829/1728-88002014-2-4-11.
16. Bogachev V.Yu., Golovanova O.V., Kuznetsov A.N., Ershov P.V. Chronic venous diseases of the lower limbs: a modern view of pathogenesis, treatment and prevention. (In Russ.) Available at: https://medi.ru/info/4739/
17. Kudykin M.N. Possibilities of treatment of symptoms of chronic diseases of lower limbs veins. Hospital-replacing technologies: Ambulatory surgery. 2019;(1-2):34-37. (In Russ.) doi: 10.21518/19951477-2019-1-2-34-37.
18. Veselov B.A. Clinical and economic efficiency of minimally invasive techniques in the treatment of varicose veins of lower extremities. Cand. of Sci. diss. (In Russ.) Available at: https:/ www.dissercat.com/content/kliniko-ekonomicheskaya-effektivnost-miniinvazivnykh-metodov-lecheniya-varikoznoi-bolezni-ni.
19. Bogachev V.Y. Chronic venous disease as a problem in young patients. Meditsinskiy sovet = Medical Council. 2015;(4):62-66. (In Russ.) doi: 10.21518/2079-701X-2015-4-62-66.
20. Jeanneret C, Jager K.A., Zaugg C.E., Hoffmann U. Venous reflux and venous distensibility in varicose and healthy veins. Eur J Vasc Endovasc Surg. 2007;34(2):232-242. doi: 10.1016/j.ejvs.2007.03.018.
21. Voronkov A.V., Gamzeleva O.Y. Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins. Hospital-replacing technologies:Ambulatory surgery. 2019;(1-2):27-33. (In Russ.) doi: 10.21518/1995-1477-2019-1-2-27-33.
22. Garner R.C., Garner J.V., Gregory S., Whattam M., Calam A. Comparison of the absorption of micronized (daflon 500mg) and non micronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and angiologiya/Sovremennaya_terapiya_hronicheskih_zabolevaniy_ ven_nighnih_konechnostey_v_fokuse_transdermalynye_flebotropnye_preparaty/#.
23. Bogachev V.Yu., Boldin B.V., Turkin P.Yu., Lobanov V.N. Mestnye preparaty v lechenii i snizhenii chastoty razvitiya nezhelatel'nykh reaktsii posle skleroterapii retikulyarnykh ven i teleangiektazov. Angiologiya i sosudistaya khirurgiya. 2019;25 (4):102-107. Rezhim dostupa: http/www.angiolsurgery. org/en/magazine/2019/4/10.htm. liquid scintillation counting. Journal of Pharmaceutical Sciences. 2002;91(1):32-40. doi: 10.1002/jps.1168.
24. Porembskaya O.Ya., Kosenko I.M. Pharmacotherapy of Chronic Venous Disease - How to Choose Appropriate Venoactive Drug? Flebologiya. 2018;(3):123-132. (In Russ.) doi: 10.17116/flebo2018123123.
25. Silambarasan T., Raja B. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Eur J Pharmacol. 2012;679(1-3):81-89. doi: 10.1016/j.ejphar.2011.12.040.
26. Allaert F.A. Metaanalysis of the impact of the principal venoactive drugs agents on malleolar venous edema. Int Angiol. 2012;31(4):310-315. Available at: https://www.miner-vamedica.it/en/journals/international-angiology/article. php?cod=R34Y2012N04A0310.
27. Bogachev V.Yu. The review of materials of the international phlebologic congress (San Diego, USA August 27-31, 2003). Angiology and Vascular Surgery. 2004;10(2):54-59. (In Russ.) Available at: http://www.angiolsurgery.org/magazine/2004/2/8. htm.
28. Savel'eva MI, Sychev DA. Potential of the Transdermal Drug Delivery Systems for the Topical Treatment of Chronic Venous Diseases. Flebologiy". Journal of Venous Disorders. 2018;12(1):40-49. (In Russ.) doi: 10.17116/flebo201812140-49.
29. Bogachev V.Yu., Boldin B.V., Turkin P.Yu. Modern therapy of chronic venous diseases of the lower limbs: focus on transdermal phlebotropic drugs. RMJ = Russian Medical Journal. 2018;6(II):61-65. (In Russ.) Available at: https://www.rmj.ru/articles/angiologiya/ Sovremennaya_terapiya_hronicheskih_zabolevaniy_ven_nighnih_ konechnostey_v_fokuse_transdermalynye_flebotropnye_prepa-raty/#.
30. Bogachev V.Yu., Boldin B.V., Turkin P.Yu., Lobanov V.N. Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia. Angiology and Vascular Surgery. 2019;25(4):102-107. (In Russ.) Available at: http://www.angi-olsurgery.org/en/magazine/2019/4/10.htm.
